This section of the site contains information
for healthcare professionals only.
The user therefore declares that they are a healthcare practitioner and are aware that, in the event of false declaration, the sanctions stipulated in the Criminal Code and the special laws on the falsification of documents shall apply to them, in accordance with Article 76 of Presidential Decree No 445 of 28.12.2000.
To access this section of the site, click YES
if you are a healthcare professional, or NO to exit
IBSA has specialised in the production of HYALURONIC ACID for 15 years
From microbial fermentation | Highly purified | Entirely manufactured in Italian factories
High molecular weight HA (800 - 1,200 kDa)
Stable hybrid cooperative complexes of high molecular weight HA (1,400 kDa) and low molecular weight HA (80 kDa)
Stable hybrid cooperative complexes of high molecular weight HA (1400 kDa) and biotechnological sodium chondroitin (40 kDa)
IBSA has developed an innovative patented microbial process to produce highly purified hyaluronic acid with controlled molecular weight. The obtained hyaluronic acid has high purity and a controlled distribution of the desired molecular weight.
In visco-supplementation therapy for the treatment of joint diseases such as osteoarthritis, it is important that the properties of the hyaluronic acid solution administered are similar to those of natural hyaluronic acid found in synovial fluid.
Therefore IBSA has developed and patented
NAHYCO® HYBRID TECHNOLOGY allows to deliver high doses of hyaluronic acid, optimising the viscous and elastic properties of the formulation and improving its resistance to degradation. This process is based on an innovative thermal system that avoids the use of chemical reagents and enables the creation of hybrid cooperative complexes of high and low molecular weight molecules, effectively reproducing the physical and mechanical properties of healthy synovial fluid and optimising the concept of visco-supplementation.
IBSA specialises in research and development,
production and marketing of hyaluronic acid-based products.
Chains of high-molecular-weight hyaluronic acid and chondroitin obtained by microbial fermentation, held together by hydrogen bonds.
High molecular weight hyaluronic acid chains and low molecular weight hyaluronic acid chains held together by hydrogen bonds.
High-molecular-weight hyaluronic acid chains and low-molecular-weight hyaluronic acid chains held together by hydrogen bonds.
LINEAR hyaluronic acid with a concentration of 1.6% (32 mg in 2 ml)
LINEAR hyaluronic acid with a concentration of 2% (50 mg in 2.5 ml)